Indivior | 销售和管理费用



Selling And Administration Expenses 更改 日
AstraZeneca USD 3.59B 1.96B 2025-03
Divis Laboratories Ltd 3.41B 440M 2025-03
Eli Lilly USD 2.36B 62.3M 2025-03
Glaxosmithkline GBP 2.7B 632M 2024-12
Halozyme Therapeutics USD 42.36M 113K 2025-03
Indivior 132M 179M 2025-03
J&J USD 5.11B 1.34B 2025-03
Kyowa Hakko Kirin JPY 42.04B 1.66B 2025-03
Merck USD 2.53B 319M 2025-03
Novartis USD 3.5B 368M 2024-12
Pfizer USD 3.01B 1.27B 2025-03
Sanofi EUR 1.24B 1.44B 2024-12
Supernus Pharmaceuticals USD 79.41M 9.66M 2024-12



Indivior 销售和管理费用 - 当前值，历史数据，预测，统计，图表和经济日历 - May 2025.